+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
South & Central America Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class; Route of Administration; Application; and Distribution Channel, and Country- Product Image
South & Central America Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class; Route of Administration; Application; and Distribution Channel, and Country- Product Image
Sale

South & Central America Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class; Route of Administration; Application; and Distribution Channel, and Country

  • PDF Icon

    Report

  • 133 Pages
  • November 2020
  • The Insight Partners
  • ID: 5231372
UP TO OFF until Jun 30th 2024
Description Jump to:
According to the publisher's new market research study on “South and Central America Gastrointestinal Drugs Market to 2027 - Regional Analysis and Forecast - by Drug Class, Route of Administration, Application, and Distribution Channel” the market is expected to reach US$ 5,632.72 million by 2027 from US$ 4,160.28 million in 2019; it is estimated to grow at a CAGR of 4.0% from 2020 to 2027. The report provides trends prevailing in the South and Central America gastrointestinal drugs market and the factors driving the market growth along with those hindering it.

In 2019, the acid neutralizers segment accounted for the highest share of the market. However, the biologics segment is expected to be the fastest-growing during the forecast period. The CAGR of the biologics segment has the highest CAGR in the forecast period. The growth of the segment is attributed to growing product development and increasing product launches in the market.

The growth of the South and Central America Gastrointestinal Drugs market is mainly attributed to rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics. However, side effects associated with the drugs will restrict the market growth.

Celltrion Healthcare Co., Ltd; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; AstraZeneca; and Takeda Pharmaceutical Company Limited are among the leading companies operating in the South and Central America Gastrointestinal Drugs market.

The Report Segments South and Central America Gastrointestinal Drugs Market as Follows:

South and Central America Gastrointestinal Drugs Market - By Drug Class
  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
  • Others

South and Central America Gastrointestinal Drugs Market - By Route of Administration
  • Oral
  • Parenteral

South and Central America Gastrointestinal Drugs Market - By Application
  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
  • Others

South and Central America Gastrointestinal Drugs Market - By Country
  • South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America


Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America gastrointestinal drugs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Gastrointestinal Drugs Market - by Drug Class
1.3.2 South and Central America Gastrointestinal Drugs Market - by Route of Administration
1.3.3 South and Central America Gastrointestinal Drugs Market - by Application
1.3.4 South and Central America Gastrointestinal drugs Market - by Distribution Channel
1.3.5 South and Central America Gastrointestinal drugs Market - by Country
2. South and Central America Gastrointestinal Drugs Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Gastrointestinal Drugs Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Gastrointestinal Drugs Market - South and Central America PEST Analysis
4.3 Expert Opinion
5. South and Central America Gastrointestinal Drugs Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases
5.1.2 Increase in Development of Biologics
5.2 Market Restraints
5.2.1 Side Effects Associated with The Drugs
5.3 Market Opportunities
5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates
5.4 Future Trends
5.4.1 Emergence of Biosimilars
5.5 Impact Analysis
6. Gastrointestinal Drugs Market - South and Central America Analysis
6.1 South and Central America Gastrointestinal Drugs Market Revenue Forecasts and Analysis
7. South and Central America Gastrointestinal Drugs Market Analysis and Forecasts to 2027 - by Drug Class
7.1 Overview
7.2 South and Central America Gastrointestinal Drugs Market, by Drug Class 2019 & 2027 (%)
7.2.1 South and Central America Gastrointestinal drugs Market Revenue and Forecasts to 2027, by Drug Class (US$ Mn)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 South and Central America Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Antidiarrheal and Laxatives
7.4.1 Overview
7.4.2 South and Central America Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Anti-Inflammatory Drugs
7.5.1 Overview
7.5.2 South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Antiemetic and Antinauseants
7.6.1 Overview
7.6.2 South and Central America Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Biologics
7.7.1 Overview
7.7.2 South and Central America Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Others
7.8.1 Overview
7.8.2 South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. South and Central America Gastrointestinal Drugs Market Analysis - by Route of Administration
8.1 Overview
8.2 South and Central America Gastrointestinal Drugs Market, by Route of Administration 2019-2027 (%)
8.2.1 South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Route of Administration (US$ Mn)
8.3 Oral
8.3.1 Overview
8.3.2 South and Central America Oral Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Parenteral
8.4.1 Overview
8.4.2 South and Central America Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)
9. South and Central America Gastrointestinal Drugs Market Analysis - by Application
9.1 Overview
9.2 South and Central America Gastrointestinal Drugs Market, by Application 2019-2027 (%)
9.2.1 South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Application (US$ Mn)
9.3 Inflammatory Ulcerative Colitis
9.3.1 Overview
9.3.2 South and Central America Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Crohn's Disease
9.4.1 Overview
9.4.2 South and Central America Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Irritable Bowel Syndrome
9.5.1 Overview
9.5.2 South and Central America Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Gastroenteritis
9.6.1 Overview
9.6.2 South and Central America Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Celiac Disease
9.7.1 Overview
9.7.2 South and Central America Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. South and Central America Gastrointestinal Drugs Market Analysis - by Distribution Channel
10.1 Overview
10.2 South and Central America Gastrointestinal Drugs Market, by Distribution Channel 2019-2027 (%)
10.2.1 South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Distribution Channel (US$ Mn)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 South and Central America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 South and Central America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Online Pharmacies
10.5.1 Overview
10.5.2 South and Central America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
11. Gastrointestinal Drugs Market Revenue and Forecasts to 2027 - Geographical Analysis
11.1 South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027
11.1.1 Overview
11.1.2 South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 South and Central America: Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.1.4 South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.5 South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.6 South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.7 South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.1.8 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Brazil: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.1.8.3 Brazil: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.8.4 Brazil: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.8.5 Brazil: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.9 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Argentina: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Argentina: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Argentina: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Argentina: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.10 Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.1.10.3 Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.10.4 Rest of South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.10.5 Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
12. Impact of COVID-19 Pandemic on South and Central America Gastrointestinal Drugs Market
12.1 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Celltrion Healthcare Co.,Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 AstraZeneca
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 Glossary of Terms
List of Tables
Table 1. South and Central America Gastrointestinal drugs Market Revenue and Forecasts to 2027, by Drug Class (US$ Mn)
Table 2. South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Route of Administration (US$ Mn)
Table 3. South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Application (US$ Mn)
Table 4. South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Distribution Channel (US$ Mn)
Table 5. South and Central America: Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 6. South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 8. South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Brazil: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
Table 10. Brazil: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Brazil: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. Brazil: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. Argentina: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
Table 14. Argentina: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. Argentina: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 16. Argentina: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
Table 18. Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 19. Rest of South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms, Gastrointestinal Drugs Market
List of Figures
Figure 1. Gastrointestinal Drugs Market Segmentation
Figure 2. South and Central America Gastrointestinal Drugs Market Overview
Figure 3. Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market
Figure 4. Brazil is Expected to show Remarkable Growth during the Forecast Period
Figure 5. South and Central America Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)
Figure 6. Gastrointestinal Drugs Market - South and Central America PEST Analysis
Figure 7. Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint
Figure 8. South and Central America Gastrointestinal Drugs market - Revenue Forecasts and Analysis-2019-2027
Figure 9. South and Central America Gastrointestinal Drugs Market, by Drug Class 2019 & 2027 (%)
Figure 10. South and Central America Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. South and Central America Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. South and Central America Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. South and Central America Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. South and Central America Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)
Figure 17. South and Central America Oral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. South and Central America Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. South and Central America Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)
Figure 20. South and Central America Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. South and Central America Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. South and Central America Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. South and Central America Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. South and Central America Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. South and Central America Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)
Figure 27. South and Central America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. South and Central America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. South and Central America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. South and Central America: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. South and Central America: Gastrointestinal Drugs Market, Revenue and Forecast to 2027 (USD Million)
Figure 32. South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
Figure 33. Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Rest of the World

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Celltrion Healthcare Co.,Ltd
  • GlaxoSmithKline plc
  • Johnson and Johnson Services, Inc.
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited

Related Topics

Related Reports

Gastrointestinal Therapeutics - Global Strategic Business Report - Product Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Global Gastrointestinal Drugs Market by Drug Category (Acid Neutralizers, Anti-Inflammatory, Antiemetic & Antinauseants), Disease Type (Gastroesophageal Reflux Disorder, Irritable Bowel Syndrome), Route of Administration, End User - Forecast 2024-2030 - Product Image

Global Gastrointestinal Drugs Market by Drug Category (Acid Neutralizers, Anti-Inflammatory, Antiemetic & Antinauseants), Disease Type (Gastroesophageal Reflux Disorder, Irritable Bowel Syndrome), Route of Administration, End User - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Global Gastrointestinal Diseases Therapeutics Market 2023-2027 - Product Image

Global Gastrointestinal Diseases Therapeutics Market 2023-2027

  • Report
  • 168 Pages
  • Global
From
Global Gastrointestinal OTC Drugs Market 2023-2027 - Product Image

Global Gastrointestinal OTC Drugs Market 2023-2027

  • Report
  • 177 Pages
  • Global
From
Gastrointestinal Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Gastrointestinal Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 102 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.